Role and function of macrophages in the metabolic syndrome (Q37983640)

26 August 2017

Role and function of macrophages in the metabolic syndrome (English)

1 reference

26 August 2017

0 references

1 reference

Prerna Bhargava

1

1 reference

PubMed ID

22329799

26 August 2017

Chih-Hao Lee

series ordinal

2

1 reference

PubMed ID

22329799

26 August 2017

language of work or name

English

0 references

publication date

1 March 2012

1 reference

26 August 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

Biochemical Journal

1 reference

26 August 2017

442

1 reference

26 August 2017

253-262

1 reference

26 August 2017

2

1 reference

The macrophage: past, present and future

26 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Tumor necrosis factor alpha inhibits signaling from the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Nutrient sensing and inflammation in metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Insulin receptor substrate-2-dependent interleukin-4 signaling in macrophages is impaired in two models of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Type 2 diabetes impairs insulin receptor substrate-2-mediated phosphatidylinositol 3-kinase activity in primary macrophages to induce a state of cytokine resistance to IL-4 in association with overexpression of suppressor of cytokine signaling-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Cytokine secretion is impaired in women with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Immune dysfunction in patients with diabetes mellitus (DM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Molecular basis of age-associated cytokine dysregulation in LPS-stimulated macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Exploring the full spectrum of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

NF-κB, inflammation, and metabolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Association of interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Interleukin-10 (-1082G/A) gene polymorphism in patients with type 2 diabetes with and without nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

The role of endoplasmic reticulum stress in the progression of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Quantifying macrophage defects in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

ABCA1 and ABCG1 protect against oxidative stress-induced macrophage apoptosis during efferocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Adipose tissue and adipokines: for better or worse

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Emerging role of adipose tissue hypoxia in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Evaluation of macrophage plasticity in brown and white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Atherosclerosis. the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Macrophages in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Obesity, Inflammation, and Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Critical role of Kupffer cells in the management of diet-induced diabetes and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Kupffer cell activation is a causal factor for hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

PPAR delta agonists and metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Dual and beneficial roles of macrophages during skeletal muscle regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

A central role for JNK in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Alternative activation of macrophages: an immunologic functional perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Deletion of tumor necrosis factor-alpha receptor 1 (TNFR1) protects against diet-induced obesity by means of increased thermogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Pathogen recognition in the innate immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

TLR4 links innate immunity and fatty acid-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

IKK-beta links inflammation to obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

The protein kinase IKKepsilon regulates energy balance in obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Modulation of atherosclerosis in mice by Toll-like receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Macrophage-specific inhibition of NF-kappaB activation reduces foam-cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Inflammasome activation: from inflammatory disease to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Molecular mechanism of NLRP3 inflammasome activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Inflammatory links between obesity and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

The inflammasomes: guardians of the body

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

HIF-1alpha is essential for myeloid cell-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

HIF-1alpha expression regulates the bactericidal capacity of phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Hypoxia inducible factor (HIF) function in innate immunity and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Chronic hypoxia activates the Akt and beta-catenin pathways in human macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Hypoxia is present in murine atherosclerotic plaques and has multiple adverse effects on macrophage lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Inflammation contributes to the atherogenic role of intermittent hypoxia in apolipoprotein-E knock out mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Nuclear receptors and lipid physiology: opening the X-files

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

PPAR delta as a therapeutic target in metabolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Nuclear receptors in macrophages: a link between metabolism and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Peroxisome proliferator-activated receptor delta promotes very low-density lipoprotein-derived fatty acid catabolism in the macrophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

PPARγ Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-inflammatory Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Control of macrophage activation and function by PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

PPAR delta: a dagger in the heart of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Omega-3 fatty acids: a comprehensive review of their role in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Identification of G protein-coupled receptor 120-selective agonists derived from PPARgamma agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Adaptations of energy metabolism in the cultivated macrophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Mechanisms of insulin resistance during acute endotoxemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Severity, duration, and mechanisms of insulin resistance during acute infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Metabolite profiles and the risk of developing diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

The TSC-mTOR signaling pathway regulates the innate inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

A stress signaling pathway in adipose tissue regulates hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Normalization of obesity-associated insulin resistance through immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

MicroRNAs: the fine-tuners of Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

MicroRNAs in diabetes: tiny players in big disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

MicroRNAs in atherosclerosis and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Muscles and their myokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

The effect of exercise and nutrition on intramuscular fat metabolism and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Role of myokines in exercise and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Effects of lifestyle interventions on inflammatory markers in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Effects of a weight reduction program with and without aerobic exercise in the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111708

21 January 2018

Identifiers

DOI

10.1042/BJ20111708

1 reference

26 August 2017

1 reference

PubMed ID

22329799